Incidence and Resolution of Eribulin-Induced Peripheral Neuropathy (IRENE) in Locally Advanced or Metastatic Breast Cancer: Prospective Cohort Study.

Hans-Joachim LückMarcus SchmidtTobias HesseOliver HoffmannBernhard J HeinrichTjoung-Won Park-SimonEva-Maria GrischkeRudolf WeideHarald Müller-HuesmannKerstin Lüdtke-HeckenkampDorothea FischerCosima ZemlinMatthias KögelJane WuHelga SchmitzChristian EngelbrechtChristian Jackisch

Published in: The oncologist (2023)

The rates of any grade and grade ≥3 eribulin-induced PN observed in this real-world study were consistent with those observed in phase III randomized clinical trials. No new safety findings were observed.

Keyphrases

metastatic breast cancer
phase iii
high glucose
locally advanced
diabetic rats
phase ii
open label
clinical trial
drug induced
randomized controlled trial
risk factors
radiation therapy
endothelial cells
neoadjuvant chemotherapy
phase ii study